Prospective Assessment of Risk Factors for Recurrent Stroke During Childhood--A 5-year Follow-up Study
Lancet 360:1540-1545,1526, Strater,R.,et al, 2002
High-Density Lipoprotein Cholesterol and Ischemic Stroke in the Elderly
JAMA 285:2729-2735, Sacco,R.L.,et al, 2001
Migrainous Visual Accompaniments are not Rare in Late Life:The Framingham Study
Stroke 29:1539-1543, Wijman,C.A.C.,et al, 1998
High-Density Lipoprotein Cholesterol & Risk of Ischemic Stroke Mortality:21-Yr FU of 8586 Men-Israeli Ischemic Heart Dis Study
Stroke 28:83-87, Tanne,D.,et al, 1997
Plasma Concentration of Lipoprotein (a) and the Risk of Future Stroke
JAMA 273:1269-1273, Ridker,P.M.,et al, 1995
Risk Factors for Cervical Atherosclerosis in patients with Transient Ischemic Attack or Minor Ischemic Stroke
Stroke 24:970-975, Palomaki,H.,et al, 1993
High Serum Lipoprotein (a) Levels Are an Independent Risk Factor for Cerebral Infarction
Stroke 24:965-969, Shintani,S.,et al, 1993
Lioporotein and Apolipoprotein Profile in Men with Ischemic Stroke
Stroke 23:1556-1562, Pedro-Botet,J.,et al, 1992
Plasma Lipoproteins in Cortical Versus Lacunar Infarction
Stroke 20:448-452, Adams,R.J.,et al, 1989
Clinical Characteristics, Risk Factors, and Outcomes of POEMS Syndrome
Neurol 95:e268-e279, Keddie, S.,et al, 2020
Cholesterol Lowering and Prevention of Stroke
Stroke 50:537-541, Hackam, D.G. & Hegele, R.A., 2019
Cerebral Infarction in POEMS Syndrome: Incidence, Risk Factors, and Imaging Characteristics
Neurol 73:1308-1312, Dupont,S.A.,et al, 2009
Hemorrhagic Stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels Study
Neurol 70:2364-2370,2355, Goldstein,L.B.,et al, 2008
Efficacy and Safety of Cholesterol-Lowering Treatment: Prospective Meta-Analysis of Data from 90056 Participants in 14 Randomised Trials of Statins
Lancet 366:1267-1278, Cholesterol Treatment Trialists (CTT) Collaborators, 2005
Effects of Cholesterol-lowering with Simvastatin on Stroke and Other Major Vascular Events in 20 536 People with Cerebrovascular Disease or Other High-Risk Conditions
Lancet 363:757-767, Heart Protection Study Collaborative Group, 2004
POEMS Syndrome Associated with Ischemic Stroke
Arch Neurol 60:745-749, Kang, K.,et al, 2003
The Neurologic Complications of Scleromyxedema
Medicine 80:313-319, Berger,J.R.,et al, 2001
HMG-CoA Reductase Inhibitors (Statins)
Neurol 54:790-795, Hess,D.C.,et al, 2000
Low-Density Lipoprotein Cholesterol and the Risk of Dementia with Stroke
JAMA 282:254-260, Moroney,J.T.,et al, 1999
Lipids and Stroke
Arch Neurol 53:303-308, Hachinski,V.,et al, 1996
Vitamin C and Risk of Death from Stroke and Coronary Heart Disease in Cohort of Elderly People
BMJ 310:1563-1566, 15481995., Gale,G.R.,et al, 1995
Chronic Central Nervous System Involvement in Lyme Borreliosis
Neurol 38:863-867, Kohler,J.,et al, 1988
Neurologic Manifestations of AIDS
Medicine 66:407-437, McArthur,J.C., 1987
Clinicopathological Conference
Case 2-1984, Fabry's Disease, NEJM 310:106-114984., , 1984
Oligoclonal IgG Bands in Cerebrospinal Fluid in Various Neurological Diseases
Ann Neurol 13:434-439, Chu,A.B.,et al, 1983
Occurrence of Oligoclonal Bands in Multiple Sclerosis & Other CNS Diseases
Ann Neurol 13:53-58, Miller,J.R.,et al, 1983
Herpes Zoster Ophthalmicus & Delayed Contra-lateral Hemiparesis Caused by Cerebral Angiitis
Ann Neurol 14:543-553, Hilt,D.C.,et al, 1983
Neurologic Manifestations in Macroglobulinemia
In Vinken PJ, Bruyn GW, Eds, Handbook of Clin Neurol, Vol 39, North-Holland Publ Co, p. 189, Abramsky,O., 1980
Cardiac Myxoma:A Diagnostic Challenge for the Neurologist
Neurol 26:1060, Yufe,R.,et al, 1976
Case Records of MGH-Polycythemia
Carotid Occlusion & Cerebral Infarcts, NEJM 291:96674., , 1974
Neuro CPC of MGH
Thromboembolism of Cerebral & Internal Carotid Arteries, NEJM 271:837-84564., , 1964